MSD
Scope
Date
~
-
Korean chipmakers
Samsung strives to prevent musculoskeletal disorders in the workplace
Samsung Electronics Co., the world’s largest memory chipmaker, is striving to prevent musculoskeletal disorders (MSDs) in its workplace to imp...
Sep 09, 2024 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm's Efinopegdutide gets Fast Track Designation from FDA
Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...
Jun 13, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to produce MSD’s new Ebola vaccine candidate
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a contract with MSD, a global pharma...
May 08, 2023 (Gmt+09:00)
-
Cell therapy
GC Lab Cell, Artiva ink $1.9 bn deal with MSD
South Korea-based biotechnology company Green Cross Lab Cell Corp. (GC Lab Cell) and its US-based subsidiary have inked a $1.9 billion deal to expor...
Jan 29, 2021 (Gmt+09:00)
Latest News
- 1 S.Korea’s GEPS to commit $143 million to foreign mid-cap buyout funds
- 2 CJ CheilJedang to open $72-mn dumpling plant in Japan
- 3 LG Electronics breaks ground on $600 million home appliance plant in India
- 4 KakaoBank posts record Q1 profit, eyes Thai expansion after Indonesia
- 5 Soon for sale: Altos Ventures-backed Cafe Knotted operator